This is an 85-year-old patient who came from Tianjin and was diagnosed with pancreatic cancer.
The patient presented with abdominal pain and underwent examinations at a local hospital, which revealed a pancreatic tumor and elevated levels of CA199. After comprehensive evaluations at the local hospital, the clinical diagnosis of pancreatic cancer was established.
For pancreatic cancer, the current main treatment methods include:
Taking into consideration the patient’s advanced age of 85 years, although there was no cancer metastasis, the limitations imposed by age meant that surgery, chemotherapy and radiation therapy were not feasible options for the patient. The local hospital was unable to provide effective treatment options, leading to consultations and negotiations that resulted in the patient being transferred to our hospital. Eventually, a decision was made to proceed with a High-Intensity Focused Ultrasound (HIFU) ablation treatment. The procedure was performed under sedation and analgesia, and the surgical outcome was favorable, with virtually no noteworthy discomfort experienced by the patient on the second day post-surgery.
Postoperative examinations revealed more than 95% ablation of the tumor, and the patient showed no signs of abdominal pain or pancreatitis. Consequently, the patient was able to be discharged on the second day.
Upon returning home, the patient could undergo combined treatments such as oral chemotherapy drugs or traditional Chinese medicine, with further follow-up visits scheduled after one month to assess the tumor’s regression and absorption.
Pancreatic cancer is an extremely aggressive malignancy, often diagnosed at advanced stages, with a median survival period of approximately 3-6 months. However, with proactive and comprehensive treatment approaches, most patients can extend their survival by 1-2 years.